Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Free Report) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $5.16 and traded as high as $5.47. Bayer Aktiengesellschaft shares last traded at $5.43, with a volume of 683,003 shares traded.
Bayer Aktiengesellschaft Stock Up 1.5 %
The company has a market capitalization of $21.34 billion, a PE ratio of -20.88 and a beta of 1.02. The firm’s 50-day simple moving average is $5.14 and its 200 day simple moving average is $6.64. The company has a debt-to-equity ratio of 1.19, a quick ratio of 0.81 and a current ratio of 1.32.
Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Free Report) last released its quarterly earnings results on Tuesday, November 12th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.10). The firm had revenue of $10.96 billion for the quarter. Bayer Aktiengesellschaft had a positive return on equity of 16.90% and a negative net margin of 2.02%. As a group, equities research analysts forecast that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current year.
Bayer Aktiengesellschaft Company Profile
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Featured Stories
- Five stocks we like better than Bayer Aktiengesellschaft
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Oilfield Leader SLB: An AI Name You Need to Know
- 3 Healthcare Dividend Stocks to Buy
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.